STRUCTURE AND METABOLISM OF LIPOPROTEIN (A)

被引:50
作者
MARCOVINA, SM
MORRISETT, JD
机构
[1] UNIV WASHINGTON,DEPT MED,NW LIPID RES LABS,SEATTLE,WA 98103
[2] BAYLOR COLL MED,DEPT MED,DIV ATHEROSCLEROSIS & LIPOPROT RES,HOUSTON,TX
关键词
D O I
10.1097/00041433-199506000-00005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An understanding of the complex structural and metabolic features of lipoprotein (a) is essential because this lipoprotein particle, with poorly recognized physiological functions, has been implicated in both thrombogenesis and atherogenesis. Studies aimed at investigating the structure-function relationship of apolipoprotein (a) have generated new useful information. In-vivo and in-vitro studies have provided insights into the synthesis, secretion, and association of apolipoprotein (a) with apolipoprotein B-100 and the mechanisms regulating the lipoprotein (a) concentration in the bloodstream.
引用
收藏
页码:136 / 145
页数:10
相关论文
共 56 条
[31]   IN-VIVO KINETICS OF LIPOPROTEIN(A) IN HOMOZYGOUS WATANABE HERITABLE HYPERLIPEMIC RABBITS [J].
LIU, R ;
SAKU, K ;
KOSTNER, GM ;
HIRATA, K ;
ZHANG, B ;
SHIOMI, M ;
ARAKAWA, K .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (09) :561-565
[32]  
LOGRASSO PV, 1994, J BIOL CHEM, V296, P21820
[33]   LIPOPROTEIN(A) - A UNIQUE RISK FACTOR FOR ATHEROTHROMBOTIC DISEASE [J].
LOSCALZO, J .
ARTERIOSCLEROSIS, 1990, 10 (05) :672-679
[34]   TRIGLYCERIDE-RICH LIPOPROTEIN INTERACTIONS WITH LP(A) [J].
MCCONATHY, WJ ;
TRIEU, VN ;
KOREN, E ;
WANG, CS ;
CORDER, CC .
CHEMISTRY AND PHYSICS OF LIPIDS, 1994, 67-8 :105-113
[35]  
MCCORMICK SPA, 1994, J BIOL CHEM, V269, P24284
[36]   CDNA SEQUENCE OF HUMAN APOLIPOPROTEIN(A) IS HOMOLOGOUS TO PLASMINOGEN [J].
MCLEAN, JW ;
TOMLINSON, JE ;
KUANG, WJ ;
EATON, DL ;
CHEN, EY ;
FLESS, GM ;
SCANU, AM ;
LAWN, RM .
NATURE, 1987, 330 (6144) :132-137
[37]   INTERACTION OF LDL AND LP[A] WITH HUMAN SKIN FIBROBLASTS [J].
MIMS, MP ;
GAUBATZ, JW ;
GHAZZALY, KK ;
VIA, DP ;
CLOUGH, DS ;
MORRISETT, JD .
CHEMISTRY AND PHYSICS OF LIPIDS, 1994, 67-8 :145-152
[38]  
MORRISETT J, 1993, DRUGS AFFECTING LIPI, P161
[39]  
MORRISETT JD, 1990, LIPOPROTEIN A, P53
[40]   OXIDATIVE MODIFICATION OF LP(A) CAUSES CHANGES IN THE STRUCTURE AND BIOLOGICAL PROPERTIES OF APO(A) [J].
NARUSZEWICZE, M ;
GIROUX, LM ;
DAVIGNON, J .
CHEMISTRY AND PHYSICS OF LIPIDS, 1994, 67-8 :167-174